02-11686. National Cancer Institute; Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis Panel, Loan Repayment Program (LRP).

    Date: June 4, 2002.

    Time: 1 p.m. to 4 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: 6116 Executive Blvd, Suite 703, Room 7142, Rockville, MD 20852. (Telephone Conference Call)

    Contact Person: Thomas M. Vollberg, PhD, Scientific Review Administrator, Special Review and Resources Branch, Division of Extramural Activities, National Cancer Institute, National Institute of Health, 6116 Executive Boulevard, Suite 703/7145, Rockville, MD 20852, 301/594-9582, vollbert@mail.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature
    Start Printed Page 31818

    Dated: May 2, 2002.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 02-11686 Filed 5-9-02; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
6/4/2002
Published:
05/10/2002
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
02-11686
Dates:
June 4, 2002.
Pages:
31817-31818 (2 pages)
PDF File:
02-11686.pdf